|

Oral Azacitidine Clinical Trials

2 actively recruiting trials across 1 location

Pipeline

Phase 4: 1

Top Sponsors

  • Virginia Commonwealth University1
  • Bristol-Myers Squibb1

Indications

  • Acute Myeloid Leukemia2
  • Cancer2

Other1 trial

A Post-Marketing Surveillance Study to Assess the Safety of Oral Azacitidine Maintenance Therapy in Korean Patients With Acute Myeloid Leukemia

Richmond, Virginia1 trial

Oral Azacitidine in Transplant-Eligible Patients With Acute Myeloid Leukemia (AML) Suffering From Health-Inequality

Virginia Commonwealth University

Phase 4

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.